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Abstract
Background: Excessive weight gain is commonly observed within the first year after kidney transplantation and is
associated with negative outcomes, such as graft loss and cardiovascular events. The purpose of this study is to evaluate
the effect of a high protein and low glycemic-index diet on preventing weight gain after kidney transplantation.
Methods: We designed a prospective, single-center, open-label, randomized controlled study to compare the
efficacy of a high protein (1.3–1.4 g/kg/day) and low-glycemic index diet versus a conventional diet (0.8–1.0 g/kg/day
of protein) on preventing weight gain after kidney transplantation. A total of 120 eligible patients 2 months after
transplantation will be recruited. Patients with an estimated glomerular filtration rate through the modification of diet
of renal disease (MDRD) formula < 30 mL/min/1.73 m2 or urinary albumin excretion > 300 mg/24 h will be excluded.
Patients’ diets will be allocated through simple sequential randomization. Patients will be followed-up for 12 months
with nine clinic appointments with a dietitian and the evaluations will include nutritional assessment (anthropometrics,
body composition, and resting metabolic rate) and laboratory tests. The primary outcome is weight maintenance or
body weight gain under 5% after 12 months. Secondary outcomes include body composition, resting metabolic rate,
satiety sensation, kidney function, and other metabolic parameters.
Discussion: Diets with higher protein content and lower glycemic index may lead to weight loss because of higher
satiety sensation. However, there is a concern about the association of high protein intake and kidney damage.
Nevertheless, there is little evidence on the impact of high protein intake on long-term kidney function outcome.
Therefore, we designed a study to test if a high protein diet with low-glycemic index will be an effective and safe
nutritional intervention to prevent weight gain in kidney transplant patients.
Trial Registration: ClinicalTrials.gov identifier, NCT02883777. Registered on 3 August 2016.
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Background
Weight gain after kidney transplantation is very often
observed and it has been reported to be between 10%
and 35%, mainly during the first year after transplant
[1–4]. Post-transplant overweight and obesity may lead
to negative post-transplant outcomes, such as graft loss
and cardiovascular events [5, 6]. In addition, weight gain
during the first year post-transplantation appears to be a
risk factor for the development of new-onset diabetes
and metabolic syndrome [7–9]. The main factors
implied in the weight gain in this population are the
immunosuppressive regimen, the cessation of dietary
restrictions associated with dialysis, consequent appetite
restoration, and improvements in quality of life [10, 11].
Data on nutritional management to prevent weight
gain after transplantation is scarce [12–17]. Moreover,
the evidence assessing protein requirements in kidney
transplant patients is also limited [15, 18]. High protein
intake in the early period post-transplant is recom-
mended to match protein catabolism, but there is no
evidence available regarding long-term protein require-
ments of stable renal-transplanted recipients [18].
A high-protein diet is known to be effective for
body weight loss and subsequent weight maintenance
in the general population [19–22]. Protein generally
exerts a better satiety effect than carbohydrates and
lipids [23–25]. During the process of weight loss, a
high-protein diet preserves lean body tissue, which is
the major determinant of resting and 24-h energy ex-
penditure, which, in turn, prevents a greater reduction
in energy expenditure [23] usually observed in indi-
viduals undergoing a weight reduction program.
Besides, it is well known that a diet with a low gly-
cemic index (GI) is determinant of postprandial meta-
bolic responses to food intake and also may have
beneficial effects on body weight and body compos-
ition [26–28]. Larsen et al. [29] have shown that a
dietary plan with moderately high protein associated
with a slightly reduced GI leads to weight loss main-
tenance in overweight adults who had lost at least 8%
of body weight. In this context, we designed a ran-
domized clinical trial in order to evaluate the effect
of a high protein and low GI diet in preventing
weight gain after kidney transplantation.
Methods/design
Study design and centers
This is a prospective, single-center, open-label, random-
ized clinical trial that will include an interventional
group (high protein and low GI diet) and a control
group (usual diet) patients that will undergo kidney
transplant at Hospital de Clínicas de Porto Alegre,
Brazil. The present protocol was written in accordance
with Standard Protocol Items: Recommendations for
Interventional Trials (SPIRIT) guideline, completing the
SPIRIT checklist, and constructing a flow diagram in
order to optimize the quality of reporting [30] (Fig. 1
and Additional file 1).
Inclusion and exclusion criteria
The study will include kidney transplant recipients who
agree to participate in the study protocol and provide writ-
ten informed consent. The exclusion criteria will be the
following: patients younger than 18 years old, prior trans-
plant, multiple organ transplant, type 1 diabetes mellitus,
current cancer, women in pregnancy or lactation period,
recipients of a kidney from living donors, patients with
urinary albumin excretion > 300 mg/24 h or estimated
glomerular filtration rate through the modification of diet
of renal disease (MDRD) formula < 30 mL/min/1.73 m2,
and/or anticipated difficulty of adherence (for example,
due to any kind of cognitive deficits or dementia).
Sample size
Sample size calculations were carried out in WINPEPI
11.20 (Brixton Health, Israel) based on data from Souza
et al. [31]. To find a difference of 5% in body weight
between groups 1 year after the transplant, considering a
standard deviation of 8.8%, a significance level of α ≤ 0.05
and a statistical power of 80%, the minimum sample size
will be 98 patients. Because of possible dropouts, we will
include 120 patients (60 randomized to each group).
Study intervention
Patients will be randomized to: 1) an intervention group
who will receive a high-protein diet (1.3–1.4 g/kg/day)
with low GI; and 2) a control group that will receive a
conventional diet that provides approximately 0.8–1.0 g/
kg of protein intake. All the patients will be followed for
12 months with nine clinic appointments made by a re-
search dietitian. The evaluations will include nutritional
assessment (anthropometrics, body composition, and
resting metabolic rate) and laboratory tests.
Randomization
The randomization will be performed through a simple
sequential randomization plan generated online (using
the randomization.com website [32]) by another
researcher (CCF).
Blinding
In this clinical trial blinding of patients and dietitians is
not possible because of evident differences between the
intervention and control group.
Data collection and timeline
Follow-up evaluation and data collection will be under-
taken over 2 years and 6 months at the Clinical Research
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Center of the Hospital de Clínicas de Porto Alegre,
Brazil, by trial personnel. All research tests will be
assessed on the same day as protocol laboratory tests.
Adherence and acceptability
In order to assess diet compliance and safety issues, all
participants will collect 24-h urine samples to measure
albumin, protein, creatinine, and urea excretion every
3 months. During the first semester, the subjects will
have a monthly nutritional visit and, during the second
semester, patients will be seen at month 9 and month 12
after randomization.
Study protocol
Kidney transplant recipients who meet the inclusion
criteria and are eligible will be invited to participate in
this study 2 months after the transplant surgery.
Patients will be randomized to the intervention group
or the control group. The intervention group will re-
ceive a high-protein (1.3–1.4 g/kg/day) and low GI diet
(preference for foods with a glycemic index ≤ 55%, with
a daily glycemic load of ≤ 80 g), and the control group
will receive a conventional diet (0.8–1.0 g/kg/day of
protein). The protein requirement will be re-evaluated
6 months after the baseline. For patients that have lost
or gained more than 5% of body weight, the diet will
be recalculated. The intervention and control groups
will receive energy-matched diets.
Demographic and clinical data will be assessed at the
first visit. Nutritional assessment will consist of: a) an-
thropometric measurements (body weight, height, calcu-
lated body mass index (BMI; kg/m2), and waist
circumference measured midway between the lowest rib
margin and the iliac crest, with flexible no-stretch fiber-
glass tape) performed at each of the nine visits; b) body
fat mass (%) measured by bioelectrical impedance
analyzer (In Body 230, GE Health Care) assessed every
3 months; and c) resting metabolic rate evaluated by in-
direct calorimetry (Meta Check 7100, Metabolic Rate
Analysis System, KOOR) at baseline and 6 months. All
the nutritional measurements will be performed with the
patient fasting, wearing light clothing, without contact
with metals, and without shoes.
Biochemical assessment will include serum and urine
creatinine (assessed monthly), fasting glycemia, choles-
terol, high-density lipoprotein (HDL) cholesterol, triglyc-
erides, glycated hemoglobin, and uric acid (assessed
every 3 months), high-sensitivity C-reactive protein (at
baseline and 6 months), and 24-h urine test for albumin,
protein, creatinine, and urea excretion (every 3 months).
The diet prescription will be calculated using nutri-
tional software (Nutribase 2007 Clinical Manager soft-
ware version 7.14). GI will be estimated as proposed by
Enrolment Baseline Post-allocation
TIMEPOINT* -t0 -t1 -t2 -t3 -t4 -t5 -t6 -t7 -t8 -t9
Eligibility screen X X X X X X X X X X
Allocation X
Informed consent X
Randomization X
INTERVENTIONS:
Nutrition Intervention
(only intervention group) X X X X X X X X
ASSESSMENTS:
Anthropometry (body 
weight and circumferences) X X X X X X X X X
Bioelectrical Impedance X X X X X
Indirect Calorimetry X X
Laboratory tests X X X X X X X X X X
Visual Analogue Scale X X
24 hours dietary recall X X X X X X X X X
Fig. 1 SPIRIT diagram. *Timepoint of the protocol: -t0, enrolment; -t1, baseline; -t2, -t3, -t4, -t5, -t6, -t7, first semester monthly appointments; -t8,
month 9; -t9, month 12
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the Food and Agriculture Organization (FAO) [33] using
the international table–United States Department of
Agriculture (USDA) table [34], with glucose as the
standard food [35] and considering a daily glycemic load
of ≤ 80 g. This will be considered as 1.3–1.4 g/kg/day of
protein. Energy intake will be assessed by a 24-h recall
over nine visits by the research dietitian. Diet compos-
ition also will be analyzed using the nutritional table
with the software (Nutribase 2007 Clinical Manager soft-
ware version 7.14) at each visit.
Two months after transplantation, patients are invited
to participate in the study protocol and are randomized
to the intervention or control group. The intervention
group receives the study diet and the control group re-
ceives the conventional diet. Both groups visit the center
once a month for the first 6 months. After that, another
two visits are scheduled at months 9 and 12. At each
visit both groups are submitted to the research
anthropometric tests and the 24-h recall diet is com-
pleted. Besides the prescription of the intervention diet
after randomization, the research dietitian reinforces diet
adherence at each visit, but only for the intervention
group. The standard diet adherence reinforcements are
more sporadic for the control group (three to four visits
scheduled per year) with the standard dietitian from the
hospital. Thus, the intervention group receives eight diet
reinforcements and the control group receives three to
four reinforcements during the study protocol.
Food intake and adherence to the prescribed diet will
be assessed by 24-h recall. An experienced registered
dietitian will implement the recall during a face-to-face
interview. To assure accurate answers, a photographic
album of food portions and household measures will in-
crease the precision of the amount of food consumed. A
total of nine records over 1 year will be available for
each included patient. Furthermore, the study protocol
also includes the collection of urinary urea excretion
and this adds to the calculation for the protein equiva-
lent of total nitrogen appearance (nPNA) as a measure
of dietary protein intake adherence.
Satiety levels will be assessed twice through a visual
analogue scale (VAS) of appetite [36]. This scale will be
answered by each patient at home 2 h after three main
meals (breakfast, lunch, and dinner) at baseline and
6 months later.
Primary outcome
The primary outcome will be weight maintenance and
weight gain under 5% of body weight.
Secondary outcomes
The secondary outcomes will consist of: a) body compos-
ition assessed every 3 months using a bioelectrical imped-
ance analyzer (patients with 12-h fasting); b) resting
metabolic rate evaluated by indirect calorimetry at base-
line and 6 months later (patients with 12-h fasting); c) sa-
tiety evaluated twice (at baseline and 6 months later) by
VAS and answered 2 h after three main meals (breakfast,
lunch, and dinner); d) kidney function assessed by serum
creatinine through estimated glomerular filtration rate
(MDRD formula) and 24-h urine test with albumin and
protein (every 3 months); e) glycated hemoglobin evalu-
ated every 3 months; f ) lipid profile evaluated every
3 months by total cholesterol, HDL cholesterol, and tri-
glycerides (with 12-h fasting) laboratory tests; and g) in-
flammation assessed through high-sensitivity C-reactive
protein at baseline and 6 months later.
Statistical analyses
Continuous variables with normal distribution will be
expressed as mean ± standard deviation. The Shapiro-Wilk
test will be used for normality assessment; asymmetrically
distributed continuous variables will be expressed as me-
dian and interquartile range; and categorical variables will
be expressed as absolute and relative frequencies. For
between-group comparisons, the Student’s t test will be
used for normally distributed variables, and the Mann–
Whitney U test for asymmetrically distributed variables. A
paired t test will be used for within-group analysis of body
weight and body composition. The Chi-square or Fisher’s
exact tests will be used to evaluate associations between
categorical variables. The generalized estimating equations
test with Bonferroni adjustment will be used for compari-
son between variables during the study period. The signifi-
cance level will be set lower than 5%, and all data will be
analyzed in SPSS 20.0 (SPSS Inc., Chicago, IL, USA).
Discussion
To the best of our knowledge, this is the first random-
ized clinical trial that will evaluate the impact of a high
protein and low GI diet on weight maintenance or
weight gain lower than 5% of body weight after kidney
transplantation. Furthermore, this study will evaluate
other relevant parameters related to metabolic out-
comes since we hypothesized that this dietetic interven-
tion may be able to improve body composition, resting
metabolic rate, satiety, inflammation, and lipid and
glycemic profiles.
Importantly, there is still concern related to a high
protein intake and kidney damage based on some previ-
ous studies that showed an association between a high
protein intake and worsening of renal function [37–40].
However, data on the impact of protein intake on long-
term outcome in kidney transplant recipients are scarce
[40–43]. Bernardi et al. evaluated a low-protein, low-
lipid, and low-sodium diet in a 12-year follow-up study
and showed a protective effect for the kidney with this
diet [40], but the interpretation of the results are limited
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and controversial. Van Den Berg et al. [41] studied the
association between protein intake and blood pressure,
proteinuria, and creatinine clearance in a cross-sectional
study with 625 renal transplant recipients, and no dele-
terious effects of the diet were identified. Interestingly,
in a cohort of 940 kidney transplant recipients, a higher
protein intake was associated with protection against
mortality and graft failure [42]. These results were con-
firmed in a more recent cohort of 604 kidney transplant
recipients with 7 years of follow-up [43]. Said et al. have
shown that a high protein intake was associated with im-
provements in muscle mass and with reduced risk of
mortality and graft failure [43], suggesting that a rela-
tively high protein intake may be beneficial to kidney
transplant recipients.
Other studies evaluating the impact of dietary inter-
ventions in kidney transplant recipients show conflicting
results, mainly limited by the study design [12–14].
Thus, due to lack of high-quality evidence data on this
issue, there are no guidelines or recommendations for a
specific nutritional intervention to manage weight gain
and obesity after kidney transplantation [44–46].
Since it is not possible to blind participants and re-
searchers involved in this study, there are possible risks
of bias. In order to diminish these risks, we will be
evaluating standard measurements of weight and other
anthropometric and laboratory tests. Furthermore, to re-
duce the potential for confounding due to measurement
variability, a single investigator will perform all the mea-
surements using the same instruments throughout the
study and the same dietitian will perform the nutrition
intervention protocol.
Trial status
The trial is ongoing. Sixty patients have started the study
protocol and additional patients are being recruited.
Additional file
Additional file 1: SPIRIT 2013 checklist: recommended items to address
in a clinical trial protocol and related documents. (DOC 122 kb)
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